Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Orchard Therapeutics plc (the “Company”) on Form 10-Q for the period ending June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers does hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: August 10, 2023 | By: | /s/ Bobby Gaspar |
Bobby Gaspar | ||
Chief Executive Officer (Principal Executive Officer) |
Date: August 10, 2023 | By: | /s/ Frank E. Thomas |
Frank E. Thomas | ||
President and Chief Operating Officer (Principal Financial Officer and Principal Accounting Officer) |